Certain Ordinary Shares of Newbury Pharmaceuticals AB (publ) are subject to a Lock-Up Agreement Ending on 27-JAN-2023. These Ordinary Shares will be under lockup for 365 days starting from 27-JAN-2022 to 27-JAN-2023.

Details:
Existing shareholders with holdings in excess of 5 percent, board members and senior executives (private and/or via companies) have undertaken to Västra Hamnen, with certain exceptions, to refrain from selling or otherwise transferring or selling their shares in the Company (”Lock-up commitment ”). The Lock-up commitment is valid for a period of 12 months from the first day of trading in the shares on First North.

In addition, all other shareholders have entered into a corresponding Lock-up commitment for a period of 3 months from the first day of trading in the shares on First North. Provided that the Offer is fully subscribed, approximately 80 percent of the shares in the Company are covered by Lock-up commitment after the Offer.